API Suppliers
0
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
0
Other Suppliers
0
0
0
USA (Orange Book)
0
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-grants-accelerated-approval-iovances-skin-cancer-cell-therapy-2024-02-16/
https://www.globenewswire.com//news-release/2023/10/16/2760639/0/en/Iovance-Biotherapeutics-Announces-Clinical-Data-for-Lifileucel-in-Advanced-Mucosal-Melanoma-at-the-European-Society-for-Medical-Oncology-ESMO-Congress.html
https://www.globenewswire.com//news-release/2023/09/14/2743715/0/en/U-S-Food-and-Drug-Administration-Updates-Prescription-Drug-User-Fee-Act-PDUFA-Action-Date-for-Lifileucel-for-the-Treatment-of-Advanced-Melanoma.html
https://www.globenewswire.com/news-release/2022/11/18/2558969/0/en/Iovance-Biotherapeutics-Provides-Update-on-Biologics-License-Application-Submission-for-Lifileucel-in-Advanced-Melanoma.html
https://www.evaluate.com/vantage/articles/news/trial-results/iovance-hammered-cell-therapy-disappoints
https://www.globenewswire.com/news-release/2022/05/26/2451584/0/en/Iovance-Biotherapeutics-Announces-Positive-Clinical-Data-for-Lifileucel-in-Advanced-Melanoma.html
https://www.globenewswire.com/news-release/2022/04/05/2417079/0/en/Iovance-Biotherapeutics-Announces-Regulatory-and-Clinical-Updates-for-Lifileucel-in-Melanoma.html
https://www.globenewswire.com/news-release/2020/05/27/2039716/0/en/Iovance-Reports-Pivotal-Cohort-4-Data-for-Tumor-Infiltrating-Lymphocyte-TIL-Therapy-Lifileucel-from-C-144-01-Clinical-Study-in-Advanced-Melanoma.html
https://endpts.com/iovance-comes-back-with-another-upbeat-cancer-trial-update-as-asco19-curtain-raiser/
https://www.prnewswire.com/news-releases/iovance-biotherapeutics-expands-partnership-with-wuxi-advanced-therapies-business-300859740.html